Isopropyl 3-(3,4-Dihydroxyphenyl)-2-hydroxypropanoate Alleviates Palmitic Acid-Induced Vascular Aging in HUVEC Cells...

Area of Science:

• Cardiovascular Science
• Cellular Biology
• Biochemistry

Background:

• Vascular aging contributes to cardiovascular diseases like hypertension and atherosclerosis.
• Hyperlipidemia and vascular wall fat accumulation are implicated in vascular aging.
• Isopropyl 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate (IDHP) shows cardiovascular protective effects potentially linked to ferroptosis.

Purpose of the Study:

• To investigate the protective effect of IDHP on hyperlipidemia-induced vascular aging.
• To elucidate the mechanism of IDHP involving senescence and ferroptosis in human umbilical vein endothelial cells (HUVECs).

Main Methods:

• Palmitic acid induction of HUVECs to model vascular aging and lipotoxicity.
• Assessment of IDHP's effects on cellular senescence markers.
• Measurement of ferrous ion accumulation, lipid peroxidation, and reactive oxygen species (ROS).
• Analysis of ferroptosis signaling pathways.

Main Results:

• IDHP treatment delayed vascular aging in HUVECs.
• IDHP reduced ferrous ion accumulation and lipid peroxidation.
• IDHP attenuated excessive ROS production and ferroptosis signaling.
• IDHP protected vascular endothelial cells from palmitic acid-induced injury.

Conclusions:

• IDHP exhibits antioxidant properties that slow lipotoxicity-induced vascular senescence.
• The protective mechanism involves regulating the ROS/ferroptosis pathway.
• IDHP demonstrates potential as a therapeutic agent for delaying vascular aging in dyslipidemia.